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Early and accurate detection of drug resistant Mycobacterium tu-
berculosis can improve both the treatment outcome and public 
health control of tuberculosis. A number of molecular-based 
techniques have been developed including ones using probe 
molecules that target drug resistance-related mutations. Although 
these techniques are highly specific and sensitive, mixed signals 
can be obtained when the drug resistant isolates are mixed with 
drug susceptible isolates. In order to overcome this problem, we 
developed a new drug susceptibility test (DST) for one of the most 
effective anti-tuberculosis drug, isoniazid. This technique em-
ployed a microplate hybridization assay that quantified signals 
from each probe molecule, and was evaluated using clinical 
isolates. The evaluation analysis clearly showed that the micro-
plate hybridization assay was an accurate and rapid method that 
overcame the limitations of DST based on conventional molec-
ular techniques. [BMB reports 2009; 42(2): 81-85]
INTRODUCTION
WHO (World Health Organization) has estimated that up to 
one third of the world’s population is infected with Myco-
bacterium tuberculosis, and that 8.8 million people worldwide 
are newly infected each year resulting in approximately 1.6 
million deaths annually (1). The global spread of tuberculosis 
(TB) is further complicated by the increasing appearance of 
multidrug-resistant (MDR) M. tuberculosis. MDR strains are de-
fined as being resistant to isoniazid (INH) and rifampin (RIF), 
which presently comprise the backbone of anti-TB chemo-
therapy. Their spread of MDR strains is a serious threat to tu-
berculosis control programs through out the world. 
    Early and accurate detection of resistant strains allows for the 
initiation of modified treatment regimens, which would im-
prove both treatment outcome of patients and public health 
control by minimizing the transmission of drug-resistant strains. 
The determination of drug resistance using phenotypic method, 
i.e., conventional culture-based drug susceptibility tests (DST), 
provides definitive results but routinely takes 6 to 10 weeks (2). 
In order to shorten this period, considerable interest has been 
generated toward developing molecular based DSTs partic-
ularly targeting RIF and INH (3-5).
    Although these molecular techniques seem to be rapid and 
highly specific, the sensitivity of the techniques involved is not 
always to be 100% accurate compared to conventional DST 
using culture methods. The reason for the problem seems to 
arise from the difficulty of molecular assays to differentiate 
mixed signals from infections with mixed strains. In the case of 
mixed strains, background signals are obtained from experi-
ments that are often carried out with inappropriate stringency. 
In addition to this, the detection limits of molecular techniques 
are lower than that of conventional culture-based DST. Accor-
ding to the Löwenstein-Jensen (LJ)-based proportional method, 
the strains are considered to be resistant to anti-tuberculosis 
drug when the ratio of the number of the bacteria colonies on 
media containing antibiotics to that of control on media with-
out antibiotics is equal to or greater than 1% at the conven-
tional culture-based method (6). For these reasons, it is critical 
to develop a molecular method that can determine the mixed 
population of the bacteria quantitatively and qualitatively.
    In an attempt to overcome these limitations, we developed 
a microplate hybridization assay, which can generate signals 
in a quantitative and qualitative manner to develop DST to 
INH.
RESULTS
Development of microplate hybridization assay for DST of M. 
tuberculosis to INH
The microplate hybridization assay developed in this study 
was designed to detect point mutations at the katG codon 315 
and the upstream promoter sequence of inhA at -15 positions, 
which are highly related to INH resistance of M. tuberculosis.
    Fig. 1 shows the representative results of the assay using 
strains of M. tuberculosis whose genotypes have been 
analyzed. In short, the results showed that microplate hybrid-
ization assay using probes for detecting single point mutations 
at each site were successful. That is, katG 315 wild type probe 
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Target gene Phenotypic pattern Microplate hybridization assay DNA sequencing No. of isolates
katG 315
15 UPS
Ra
Sb
R
S
WT (＋), MT (−)
WT (−), MT (＋)
WT (−), MT (−)
WT (＋), MT (−)
WT (＋), MT (−)
WT (−), MT (＋)
WT (＋), MT (＋)
WT (＋), MT (−)
No mutation
AGC → ACC (Ser → Thr)
AGC → AAC (Ser → Asn)
Total deletion of katG gene
No mutation
No mutation
−15 C → T
−15 C → T ＋ No mutation
No mutation
45
45
  1
  1
29
68
22
  2
29
Cut off value = means ± SD. a: INH-resistance, b: INH-susceptible
Table 1. Microplate hybridization assay results for the detection of mutations conferring INH resistance in comparison with DNA sequencing data of 
INH-resistant and INH-susceptible strains
Fig. 1. Representative patterns of clinical isolates obtained by mi-
croplate hybridization assay. (A) Representative results obtained 
from hybridization of the microplate. The positions of the oligo-
nucleotides are given on the left side. (B) The results were as-
sessed by reading absorbance values at 450 nm. Pattern 1, strain 
with the katG 315WT/15 UPSWT; pattern 2, strain with the katG
315WT/15 UPSMT; pattern 3, strain with the katG 315MT/15 UPSWT; 
pattern 4, strain with the katG 315MT/15 UPSMT; pattern 5, strain 
with the katG 315 gene deletion or strain carried the other muta-
tions in katG 315 and 15 UPS mutant type; pattern 6 is the neg-
ative control. W: wild type, M: mutant type, NC: negative 
control. The experiments were performed at least three times, and 
the result of one representative experiment is shown.
(katG 315 WT) hybridized to a strain that contained wild type 
sequences at the katG 315 site, whereas the same probe did 
not hybridize to a reference strain that contained mutated se-
quences at the katG 315 site. In addition, the katG 315 mutant 
probe (katG 315 MT), which was designed to detect the katG 
315 AGC → ACC mutation, hybridized to a reference strain 
that contained AGC → ACC mutation at the katG 315 but not 
to a reference strain that contained wild type sequences at the 
katG 315 site. Likewise, the wild type probe to -15 site of up-
stream promoter sequences (15 UPS) of inhA hybridized to a 
reference strain that contained wild type sequences at the 15 
UPS wild type sequences, whereas it did not hybridize to a 
mutated sequences of the 15 UPS. On the contrary, the probe 
designed to detect C → T change at 15 UPS hybridized to a 
reference strain that contained C → T change at 15 UPS site, 
and not to a reference strain that contained wild type se-
quences at the 15 UPS site.
Comparison of DST result using microplate hybridization 
assay with conventional culture-based DST 
In order to evaluate the sensitivity and the specificity of DST 
using the microplate hybridization method, 92 INH-resistant 
and 29 INH-susceptible M. tuberculosis isolates that were de-
termined by conventional culture-based DST were analyzed. 
The mutations at katG 315 were detected in 47 cases among 
92 INH-resistant isolates, which were determined by not hy-
bridizing to the katG 315 WT probes (Table 1). Among these, 
45 isolates hybridized to katG 315 MT indicating the presence 
of katG 315 AGC → ACC mutations in INH-resistant clinical 
isolates. Subsequent sequence analysis revealed that all the 45 
isolates studied possessed a katG 315 AGC → ACC sub-
stitution. The remaining two isolates did not hybridize to katG 
315 WT probes and the katG 315 MT probes. Sequence analy-
sis confirmed that one had the AGC → AAC mutation while 
the other had a total deletion of the katG gene. On the other 
hand, all the 29 INH-susceptible M. tuberculosis isolates hybri-
dized to the katG 315 WT probes, indicating no sequence al-
terations at that site in these strains.
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Fig. 2. Detection rates of mutant type genomic DNA that mixed 
with wild type genomic DNA. The mutant type genomic DNAs 
were used at ratios ranging from 1-10%. (A) Genomic DNA that 
was mixed with wild and mutant type of katG 315 genes was 
used. (B) Genomic DNA that was mixed with wild and mutant 
type of 15 UPS was used. Microplate hybridization assay detected 
the katG 315 and the 15 UPS mutant type genomic DNA from 
the ratio of 1% mixed with wild type gene respectively. The total 
template concentration used was 2 ng. Wa: wild type genomic 
DNA, Mb: mutant type genomic DNA.
Isolates 
(No.)
Microplate hybridization assay results
katG 315 15 UPS
WT (%) MT (%) WT (%) MT (%)
Sequencing 
results (92)
katG 315
15 UPS
WTa (45)
MTb (47)
WT (68)
MT (24)
45 (100)
  0 (100)
-
-
  0 (100)
47 (100)
-
-
-
-
68 (100)
  0 (100)
-
-
  0 (100)
24 (100)
a: wild type, b: mutant type
Table 2. Comparison of microplate hybridization assay results and 
DNA sequencing data for the detection of M. tuberculosis with muta-
tion in katG 315 and 15 UPS
    The mutations at 15 UPS were detected in 24 cases among 
92 INH-resistant isolates by using the 15 UPS mutant probe 
(15UPS MT) (Table 1). All the isolates that hybridized to 
15UPS MT were confirmed to carry a base substitution C to T 
at 15 UPS site by DNA sequence analysis. On the other hand, 
2 of 24 hybridized both to 15UPS MT and 15UPS WT probe at 
the same time. The sequence analysis of both these isolates 
showed that two genotypically different populations of M. tu-
berculosis isolates existed having wild type and mutant type C 
→ T sequences indicating the presence of both INH-resistant 
stains and INH-susceptible strains.
    Then, the detection rate of the microplate hybridization as-
say, when genomic DNA containing drug resistance related se-
quence alterations were mixed with wild type genomic DNA 
was evaluated (Fig. 2). For this, genomic DNA with mutated 
sequences was mixed with wild type genomic DNA in ratios 
of 1:99 to 10:90, and then the microplate hybridization assay 
was performed using the mutant probes. The results showed 
that the microplate hybridization assay was able to detect ge-
nomic DNA with mutated sequences even at a ratio of 1:99. 
This indicated that the microplate hybridization assay could 
successfully detect 1% population of drug resistant clinical iso-
lates mixed with 99% drug-susceptible isolates. This im-
plicated the microplate hybridization assay to be as sensitive 
as culture-based DST which detects the drug resistance of M. 
tuberculosis when the proportion of resistant clinical isolates 
are more than 1%.
Sensitivity and specificity of the microplate hybridization assay
To determine the sensitivity of each probe, 1 ng to 10 fg of 
wild type and mutant type DNA of katG 315 and 15 UPS were 
used. In the microplate hybridization assay, positive signals 
were obtained with 1 pg to 10pg at the katG 315 wild type, 15 
UPS wild type and mutant type probe, and it was obtained 
with 100 fg to 1 pg at the katG 315 mutant type probe (data 
not shown).
    By using the microplate hybridization assay, a total of the 
INH-resistant clinical isolates 68 (74%) INH-resistant M. tuber-
culosis was confirmed as INH resistance and all the 29 (100%) 
INH-susceptible M. tuberculosis was confirmed as INH sus-
ceptible. These results were confirmed by sequence analysis to 
determine the accuracy of the assay. The results revealed that 
all the mutant type and the wild type hybridization patterns of 
the katG 315 and the 15 UPS were correctly concordant with 
the sequencing data (Table 2). Therefore, the overall sensitivity 
and specificity of the microplate hybridization assay were 74% 
based on the conventional method and 100% based on the se-
quence analysis, respectively.
DISCUSSION
In the management of mycobacterial infections, the rapid de-
tection and appropriate treatment with susceptible drugs are 
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crucial. These goals can be achieved by improving the diag-
nosis of drug-resistant tuberculosis using molecular methods. 
In the present study, a microplate hybridization assay for early 
and accurate detection of INH resistance in M. tuberculosis 
was established. The probes were able to screen wild and mu-
tant genotypes at katG 315 and 15 UPS. The assay was per-
formed on 92 INH-resistant and 29 INH-susceptible isolates. 
By use of the microplate hybridization assay, the mutations at 
katG 315 were accurately detected in 51% (47/92) INH-resi-
stant M. tuberculosis isolates, similar to that previously reported. 
Among them, 45 isolates had Ser315Thr amino acid replace-
ment and one of the remaining two isolates had an AGC → 
AAC (Ser → Asn) mutation, while another had a total deletion 
of the katG gene, respectively. Mutation in the katG 315 (AGC 
→ AAC) and total deletion of the katG gene seem to be rare, 
but have previously been reported (7).
    The base substitution (C → T) at 15 UPS was detected in 
26% (24/92) INH-resistant isolates. Among these, two isolates 
were confirmed to possess INH resistance mixed with suscep-
tible strains. In this case, the microplate hybridization assay de-
tected both strains simultaneously. Furthermore, it was able to 
detect less than 1% of mutant type DNA in the mixture. These 
results have important implications compared to other molec-
ular approaches, which have a detection limit of 10% mutant 
type DNA in a mixture of wild type and mutant type DNA.
    By analyzing the katG 315 gene and 15 UPS, 74% of the 
INH-resistant M. tuberculosis were detected. This detection 
rate is very high, as approximately 10 to 25% of INH-resistant 
strains do not contain mutations in any known gene targets for 
INH resistance (8, 9). In addition, 100% of the INH-susceptible 
M. tuberculosis was confirmed as INH susceptible strains. 
When the mutant type and the wild type hybridization patterns 
of the microplate hybridization assay were compared to DNA 
sequencing, all the results were correctly concordant with the 
sequencing data. 
    The microplate hybridization assay has several advantages 
compared to conventional oligonucleotide hybridization assays. 
Firstly, the assay is easy to perform and interpret, and it utilizes 
multipurpose equipments that are available in any basic molec-
ular biology laboratory and could therefore be performed in rou-
tine clinical microbiology laboratories. Secondly, with this as-
say, INH resistance in M. tuberculosis isolates can be accurately 
predicted within just 4 hours after PCR amplification, and can 
therefore shorten the regular laboratory turnaround time for INH 
susceptibility testing. Thirdly, the assay made it possible to han-
dle a greater number of samples at the same time, thus leading to 
the development of an automated assay procedure for detection 
of INH resistance. Most importantly, when the clinical isolates 
were mixed with drug-resistant and susceptible strains, the mi-
croplate hybridization assay successfully detected both strains 
simultaneously up to the level of conventional culture-based 
DST methods. Therefore, the microplate hybridization assay has 
proven to be accurate, rapid and simple, and also overcomes the 
limitations of conventional-molecular based DST.
    On the other hand, one must be aware that the microplate 
hybridization assay has the limitations of other molecular tests 
for the detection of antibiotic resistance, and therefore, it may 
not be able to totally replace the traditional culture-based 
method for DST. This is basically due to the fact that none of 
the molecular tests previously established has targeted all pos-
sible genes or mechanisms involved in resistance, and thus, a 
variable proportion of resistant stains will not be detected. The 
second inherent limitation of this newly developed technique 
is that it utilizes DNA extraction, which is isolated from cul-
tured bacteria. Thus, information about the molecular mecha-
nisms of INH resistance and study for direct application to 
clinical specimens were required to be used routinely in clin-
ical laboratories.
MATERIALS AND METHODS
Clinical isolates of M. tuberculosis
One hundred and twenty one clinical isolates of M. tuber-
culosis consisting of 92 INH-resistant and 29 INH-susceptible 
isolates were used in this study. All the clinical isolates and 
clinical drug resistance-susceptibility profiles of these isolates 
were obtained from the Masan National TB Hospital.
Genomic DNA extraction
Genomic DNA of clinical isolates was extracted using the chloro-
form-isoamyl alcohol method, as previously described (10). 
PCR primers and oligonucleotide probes for microplate 
hybridization assay
The design of primers and probes used in this assay was based 
on the sequences of M. tuberculosis H37Rv obtained from 
GeneBank (http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db 
=Nucleotide&dopt=GenBank&val=41352722). The target 
sequences involved in katG and inhA mutation refer to 
Ramaswamy et al (5). Two sets of primers for PCR amplifica-
tion and for sequencing were designed to amplify the katG 
315 gene and 15 UPS. Both the reverse primers were bio-
tin-labelled at 5' end. The primers were katG 315 F (AGAGCT 
CGTATGGCACCGGA) and katG 315R* (CCAGCAGGGCTCT 
TCGTCAG) for katG region, and inhA-1F (ACGCTCGTGGCAT 
ACCGATT) and inhA-1R* (TCACATTCGACGCC AAACAG) for 
15UPS region. Four probes were used for microplate hybrid-
ization assay. Two probes, katG 315 WT (TCACCAGCGGCAT 
CGAGG) and 15 UPS WT (CCGCGGCGAGACGATAGG), 
were designed to detect the wild type genotypes as each own, 
respectively whilst two further probes, katG 315 MT (GATCAC 
CACCGGCATCGAGG) and 15 UPS MT (CCGCGGCGAGATG 
ATAGG), were designed to detect the most frequently seen 
genotype at each locus, katG 315 AGC → ACC and 15 UPS C → T, 
respectively. All the oligonucleotide probes were labeled at 
the 5' end with digoxigenin. The nucleotide sequences of the 
primers and the probes were analyzed with the BLAST search 
(http://www.ncbi.nlm.nih.gov) to confirm the uniqueness of 
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each primer and probe.
    Biotin-labeled and unlabeled PCR primers and digoxigenin 
linked oligonucleotide probes for microplate hybridization as-
say were synthesized by the Bioneer (Daejeon, Korea) and 
Sigma-Proligo (The Woodlands, TX, USA), respectively.
PCR amplification
Biotinylated target PCR products were generated in Accu-
Power PCR PreMix (Bioneer, Daejeon, Korea) containing Taq 
DNA polymerase 2.5 U; dNTP (dATP, dCTP, dGTP, dTTP) 250 
uM; Tris-HCl (pH 9.0) 10 mM; KCl 40 mM; MgCl2 1.5 mM; 
stabilizer and tracking dye. Ten picomol of each primer and 2 
μl of the extracted DNA (1-10 ng/μl) were added to PCR 
PreMix tube. PCR was performed with initial denaturation step 
of 95oC for 5 min before 35 cycles of 95oC for 30 s, 58oC for 
30 s and 72oC for 30 s and then a final step of 72oC for 7 min 
for the last cycle (model GeneAmpⓇ PCR system 2700, Perkin- 
Elmer Biosystems).
DNA sequence analysis
This was conducted using Genotech (Daejeon, Korea) with the 
primers used for PCR amplification. The Chromas software was 
used to analyze the sequencing data obtained from Genotech 
(http://www.technelysium.com.au/chromas14x.html).
Microplate hybridization assay
Microplate hybridization assay was performed using the fol-
lowing protocols. Briefly, in order to prepare the sample, am-
plified PCR product was diluted 4 fold with purified water. 
Each diluted double strand-PCR product was added to the 
Streptavidin coated microplate (Nunc, nunc immobilizerTM 
streptavidin, Denmark) wells. To hybridize, after denaturation 
of the double strand-PCR product, each diluted probe was add-
ed to the wells and incubated at 60oC for 1 hour. The micro-
plate was then washed three times with washing buffer at 60oC 
for 10 min with 50 rpm shaking, and then incubated with an-
ti-Digoxigenin-peroxidase (Roche, no. 11 207 733 910). After 
the plate wells were washed with washing buffer, substrate sol-
ution containing equal volume of TMB (3,3',5,5'-tetrametyl 
benzidine, sigma, no. T0440) and 0.1% H2O2 was added and 
color was allowed to develop for 10 min. Finally, the reaction 
was stopped with 1 N HCl. The absorbance value of the re-
action mixture at 450 nm was determined using a microplate 
reader (Molecular Devices, U.S.A).
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